Search Results - "SIEGALL, C"

Refine Results
  1. 1

    Development of potent monoclonal antibody auristatin conjugates for cancer therapy by Senter, Peter D, Doronina, Svetlana O, Toki, Brian E, Torgov, Michael Y, Mendelsohn, Brian A, Cerveny, Charles G, Chace, Dana F, DeBlanc, Ron L, Gearing, R Patrick, Bovee, Tim D, Siegall, Clay B, Francisco, Joseph A, Wahl, Alan F, Meyer, Damon L

    Published in Nature biotechnology (01-07-2003)
    “…We describe the in vitro and in vivo properties of monoclonal antibody (mAb)-drug conjugates consisting of the potent synthetic dolastatin 10 analogs…”
    Get full text
    Journal Article
  2. 2

    Agonistic properties and in vivo antitumor activity of the anti-CD40 antibody SGN-14 by FRANCISCO, J. A, DONALDSON, K. L, CHACE, D, SIEGALL, C. B, WAHL, A. F

    Published in Cancer research (Chicago, Ill.) (15-06-2000)
    “…Ligation of CD40 is essential for primary B-cell activation and expansion and yet has suppressive or apoptotic effects on some CD40-expressing neoplasia…”
    Get full text
    Journal Article
  3. 3

    Characterization of vascular leak syndrome induced by the toxin component of Pseudomonas exotoxin-based immunotoxins and its potential inhibition with nonsteroidal anti-inflammatory drugs by SIEGALL, C. B, LIGGITT, D, CHACE, D, MIXAN, B, SUGAI, J, DAVIDSON, T, STEINITZ, M

    Published in Clinical cancer research (01-03-1997)
    “…Clinical trials of immunotoxins in cancer patients have been limited in many cases by vascular leak syndrome (VLS). Recently, rats were identified as a model…”
    Get full text
    Journal Article
  4. 4

    Targeted toxins as anticancer agents by Siegall, C B

    Published in Cancer (01-08-1994)
    “…Transformed cells, such as those found in breast cancer, often overexpress a variety of cell surface receptors and antigens. Antibodies or growth factors that…”
    Get more information
    Journal Article
  5. 5

    Characterization of an Interleukin-6-Mediated Autocrine Growth Loop in the Human Multiple Myeloma Cell Line, U266 by Schwab, Gisela, Siegall, Clay B., Aarden, Lucien A., Neckers, Leonard M., Nordan, Richard P.

    Published in Blood (01-02-1991)
    “…It has been reported recently that freshly isolated human myeloma cell cultures proliferate in response to added interleukin-6 (IL-6). Endogenous levels of…”
    Get full text
    Journal Article
  6. 6

    Functional Analysis of Domains II, Ib, and III of Pseudomonas exotoxin by Siegall, C B, Chaudhary, V K, FitzGerald, D J, Pastan, I

    Published in The Journal of biological chemistry (25-08-1989)
    “…Pseudomonas exotoxin is composed of three structural domains that are responsible for cell recognition, membrane translocation, and ADP-ribosylation. The…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Prevention of Immunotoxin-Mediated Vascular Leak Syndrome in Rats with Retention of Antitumor Activity by Siegall, Clay B., Liggitt, Denny, Chace, Dana, Tepper, Mark A., Fell, H. Perry

    “…Immunotoxins are hybrid molecules composed of a cell-surface binding domain and a protein toxin moiety that together target specific cell populations for…”
    Get full text
    Journal Article
  9. 9

    BR96 sFv-PE40 Immunotoxin: Nonclinical Safety Assessment by Haggerty, H.G., Warner, W.A., Comereski, C.R., Peden, W.M., Mezza, L.E., Damle, B.D., Siegall, C.B., Davidson, T.J.

    Published in Toxicologic pathology (01-01-1999)
    “…BR96 sFv-PE40, a recombinant DNA-derived fusion protein composed of the heavy- and light-chain variable region domains of the monoclonal antibody BR96 and the…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    In vitro and in vivo characterization of BR96 sFv-PE40. A single-chain immunotoxin fusion protein that cures human breast carcinoma xenografts in athymic mice and rats by Siegall, CB, Chace, D, Mixan, B, Garrigues, U, Wan, H, Paul, L, Wolff, E, Hellstrom, I, Hellstrom, KE

    Published in The Journal of immunology (1950) (01-03-1994)
    “…BR96 sFv-PE40 is a single-chain immunotoxin fusion protein targeted to the Ley Ag, which is expressed in many different human carcinomas as well as in normal…”
    Get full text
    Journal Article
  11. 11

    Antitumor activity of the single-chain immunotoxin BR96 sFv-PE40 against established breast and lung tumor xenografts by Friedman, PN, Chace, DF, Trail, PA, Siegall, CB

    Published in The Journal of immunology (1950) (01-04-1993)
    “…We have constructed a single-chain immunotoxin consisting of the variable H and L chains of the carcinoma-reactive mAb BR96, fused to the binding defective…”
    Get full text
    Journal Article
  12. 12

    Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen by FRANCISCO, J. A, GILLILAND, L. K, STEBBINS, M. R, NORRIS, N. A, LEDBETTER, J. A, SIEGALL, C. B

    Published in Cancer research (Chicago, Ill.) (15-07-1995)
    “…We have constructed anti-CD40 immunotoxins consisting of the single chain Fv (sFv) region of the anti-human CD40 mAb G28-5 fused to a truncated form of…”
    Get full text
    Journal Article
  13. 13

    In Vivo Efficacy and Toxicity of a Single-Chain Immunotoxin Targeted to CD40 by Francisco, Joseph A., Schreiber, George J., Comereski, Chuck R., Mezza, Laurence E., Warner, Garvin L., Davidson, Thomas J., Ledbetter, Jeffrey A., Siegall, Clay B.

    Published in Blood (15-06-1997)
    “…G28-5 sFv-PE40 is a single-chain immunotoxin targeted to CD40, which is highly expressed on human hematologic malignancies, including non-Hodgkin's lymphoma,…”
    Get full text
    Journal Article
  14. 14

    Cytotoxic activities of a fusion protein comprised of TGF alpha and Pseudomonas exotoxin by Siegall, C B, Xu, Y H, Chaudhary, V K, Adhya, S, Fitzgerald, D, Pastan, I

    Published in The FASEB journal (01-12-1989)
    “…A cDNA encoding transforming growth factor type alpha (TGF alpha) was fused to the 5' end of a gene encoding a modified form of Pseudomonas exotoxin A (PE),…”
    Get more information
    Journal Article
  15. 15

    Cytotoxic effects of a recombinant chimeric toxin on rapidly proliferating vascular smooth muscle cells by EPSTEIN, S. E, SIEGALL, C. B, BIRO, S, YA-MIN FU, FITZGERALD, D, PASTAN, I

    Published in Circulation (New York, N.Y.) (01-08-1991)
    “…Restenosis after percutaneous transluminal coronary angioplasty is associated with activation of medial smooth muscle cells (SMCs); they proliferate, migrate…”
    Get full text
    Journal Article
  16. 16

    Selective tumor sensitization to taxanes with the mAb‐drug conjugate cBR96‐doxorubicin by Wahl, Alan F., Donaldson, Karen L., Mixan, Bruce J., Trail, Pamela A., Siegall, Clay B.

    Published in International journal of cancer (15-08-2001)
    “…The chimeric monoclonal antibody cBR96 conjugated to doxorubicin (cBR96‐Dox) is selectively internalized by a wide variety of human carcinomas expressing an…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Cytotoxic Activity of an Interleukin 6--Pseudomonas Exotoxin Fusion Protein on Human Myeloma Cells by Siegall, Clay B., Chaudhary, Vijay K., FitzGerald, David J., Pastan, Ira

    “…A chimeric toxin composed of human interleukin 6 (IL-6) attached to a portion of Pseudomonas exotoxin (PE) devoid of its own cell recognition domain has been…”
    Get full text
    Journal Article
  19. 19

    BR96 sFv-PE40, a potent single-chain immunotoxin that selectively kills carcinoma cells by FRIEDMAN, P. N, MCANDREW, S. J, GAWLAK, S. L, CHACE, D, TRAIL, P. A, BROWN, J. P, SIEGALL, C. B

    Published in Cancer research (Chicago, Ill.) (15-01-1993)
    “…We have constructed a single-chain immunotoxin composed of the carcinoma-reactive antibody BR96 and a truncated form of Pseudomonas exotoxin. The chimeric…”
    Get full text
    Journal Article
  20. 20

    Betacellulin-Pseudomonas toxin fusion proteins bind but are not cytotoxic to cells expressing HER4; correlation of EGFR for cytotoxic activity by MIXAN, B, COHEN, B. D, BACUS, S. S, FELL, H. P, SIEGALL, C. B

    Published in Oncogene (05-03-1998)
    “…Betacellulin (BTC) is a member of the EGF ligand family that directly binds to both EGFR and HER4 and induces the growth of certain epithelial cell types…”
    Get full text
    Journal Article